Clover Health Investments, Corp.
CLOV
$2.49
$0.041.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.53% | 34.27% | 33.71% | 8.86% | 7.23% |
| Total Other Revenue | 108.42% | 22.55% | 14.62% | 36.91% | 75.22% |
| Total Revenue | 50.05% | 34.07% | 33.45% | 9.28% | 8.29% |
| Cost of Revenue | 69.54% | 52.20% | 33.29% | -2.69% | 5.93% |
| Gross Profit | -9.89% | -7.68% | 33.95% | 60.30% | 16.26% |
| SG&A Expenses | 7.71% | 9.88% | 5.69% | 6.62% | -11.22% |
| Depreciation & Amortization | 19.76% | 19.39% | 46.54% | -48.96% | -39.14% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.10% | 40.04% | 25.55% | 0.03% | 0.70% |
| Operating Income | -161.47% | -237.85% | 94.42% | 57.07% | 71.14% |
| Income Before Tax | -177.48% | -247.53% | 94.50% | 68.38% | 73.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -177.48% | -247.53% | 94.50% | 68.38% | 73.87% |
| Earnings from Discontinued Operations | -- | -- | -- | 75.82% | 95.29% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -166.27% | -242.79% | 93.35% | 68.65% | 77.92% |
| EBIT | -161.47% | -237.85% | 94.42% | 57.07% | 71.14% |
| EBITDA | -166.82% | -227.22% | 96.41% | 57.18% | 71.70% |
| EPS Basic | -154.01% | -236.84% | 93.40% | 69.31% | 78.33% |
| Normalized Basic EPS | -149.58% | -232.65% | 94.54% | 58.00% | 71.67% |
| EPS Diluted | -154.01% | -298.10% | 93.40% | 68.83% | 78.33% |
| Normalized Diluted EPS | -149.58% | -235.42% | 94.54% | 58.00% | 71.67% |
| Average Basic Shares Outstanding | 4.60% | 4.42% | 2.20% | 2.13% | 1.96% |
| Average Diluted Shares Outstanding | 4.60% | 2.80% | 2.20% | 2.13% | 1.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |